Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Bloodbath Signals Biotech Bubble Bursting?

This episode of The Motley Fool's Market Checkup drills down on the hottest headlines and biggest market movers in the health-care sector. 

In this video, health-care analysts David Williamson and Max Macaluso discuss Washington, D.C.'s impact on health-care stocks. This time, it isn't the Obamacare or the ongoing government shutdown but the threat of breaching the debt ceiling that has investors spooked for a second straight day.

Shares of the Nasdaq Biotechnology index fell again, adding another 2% decline to yesterday's sell-off while the S&P Biotech index plunged an additional 4%, far underperforming the broader market.

While the carnage wasn't as universal as yesterday's bloodbath, we still saw a a wide swath of popular biotech stocks sharply decline. During turbulent times, investors often take their money out of volatile small-cap stocks, especially ones that have seen such strong performance over the last 12 months.

Watch and find out which stocks were hit the hardest and whether the biotech bubble has burst.

More Foolish insight
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2676136, ~/Articles/ArticleHandler.aspx, 9/30/2016 1:17:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,322.98 179.53 0.99%
S&P 500 2,170.32 19.19 0.89%
NASD 5,315.09 45.93 0.87%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 1:00 PM
AEGR $2.90 Down -0.16 -5.23%
Aegerion Pharmaceu… CAPS Rating: **
IBB $289.75 Up +3.88 +1.36%
iShares NASDAQ Bio… CAPS Rating: ****
IONS $36.59 Up +1.02 +2.87%
Ionis Pharmaceutic… CAPS Rating: *****
MNTA $11.71 Up +0.32 +2.81%
Momenta Pharmaceut… CAPS Rating: ***
SRPT $62.09 Up +1.11 +1.82%
Sarepta Therapeuti… CAPS Rating: **